Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 26 Jun 2026 for Ionis Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleEric Swayze
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eric Swayze: trading record in brief
Eric Swayze, listed as senior executive, appears in our data through filings on Ionis Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 30 filings cover trades dated from 18 January 2022 to 25 June 2026.
Sales make up the whole of the open-market record (10 sales, €2.2M). No amount is published for 1 filing, which the totals therefore leave out. The rest of the record consists of 3 share grants and 11 option exercises. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 26 June 2026 with an open-market sale in Ionis Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Swayze
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
10,602 sharesCommon StockSEC:0000874015-26-000211:0
256 shares@ US$48.86650.2% of flowCommon StockSEC:0000874015-26-000125:0
9,435 shares@ US$81.559215.1% of flowCommon StockSEC:0000874015-26-000111:0
11,991 shares0Common StockSEC:0000874015-26-000102:0
21,366 shares0Common StockSEC:0000874015-26-000072:0
5,125 shares@ US$60.895.3% of flowCommon StockSEC:0000874015-26-000026:0
125 shares0Common StockSEC:0000874015-25-000262:0
6,849 shares@ US$69.0212.0% of flowCommon StockSEC:0000874015-25-000254:0
14,142 shares@ US$53.770.0050% mcap48.8% of flowCommon StockSEC:0000874015-25-000245:0
10,000 shares@ US$49.2214.2% of flowCommon StockSEC:0000874015-25-000224:0
415 shares@ US$28.21150.4% of flowCommon StockSEC:0000874015-25-000103:0
3,714 shares0Common StockSEC:0000874015-25-000081:0
19,111 shares0Common StockSEC:0000874015-25-000065:0
1,194 shares@ US$37.9211.3% of flowCommon StockSEC:0000874015-24-000241:0
125 shares0Common StockSEC:0000874015-24-000229:0
1,940 shares@ US$49.56132.8% of flowCommon StockSEC:0000874015-24-000196:0
11 shares@ US$38.6410.0% of flowCommon StockSEC:0000874015-24-000221:0
605 shares@ US$34.4250.6% of flowCommon StockSEC:0000874015-24-000126:0
10,773 shares@ US$52.0016.2% of flowCommon StockSEC:0000874015-24-000110:0
17,069 shares0Common StockSEC:0000874015-24-000078:0
27,100 shares@ US$47.3436.1% of flowCommon StockSEC:0000874015-24-000006:0
125 shares0Common StockSEC:0000874015-23-000203:0
575 shares@ US$30.5150.5% of flowCommon StockSEC:0000874015-23-000115:0
3,715 shares0Common StockSEC:0000874015-23-000096:0
15,780 shares0Common StockSEC:0000874015-23-000069:0
25 of 30 declarations
